Medical News

RSS

CLASS Act, individual mandate draw new attention to health bills

Some provisions in the health bills are attracting a new wave of analyses and some criticism of the health reform bills.

18 Nov 2009

A selection of today's opinions and editorials

Rather than work with us to find a true compromise, members who support abortion rights ignored our concerns (Rep. Bart Stupak, D-Mich., 11/18).

18 Nov 2009

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.

18 Nov 2009

Seniors struggle with drug costs while Congress debates Medicare 'doughnut hole'

Minnesota Public Radio reports: "Since 2006, senior citizens have been able to choose plans for Medicare prescription drug coverage, but that coverage contains a gap known as the 'doughnut hole,' a gap that health care reform plans being debated in Congress would address."

18 Nov 2009

Green tea prevents the development of hepatic fibrosis in rat model of DMN-induced liver fibrosis

Several studies have shown that lipid peroxidation stimulates collagen production in fibroblasts and hepatic stellate cells (HSC), and plays an important role in the development of liver fibrosis. Hepatoprotective effects of green tea against carbon tetrachloride, cholestasis and alcohol induced liver fibrosis were reported in many studies. However, the hepatoprotective effect of green tea in dimethylnitrosamine (DMN)-induced models has not been studied.

18 Nov 2009

White House reports billions lost in improper payments for Medicare, other government programs

The White House announced Tuesday that billions of federal dollars were spent in improper payments in 2009 and that spending in the Medicare and Medicaid programs accounted for more than half of that total. President Barack Obama will issue an executive order to crack down on the problem, officials said.

18 Nov 2009

States mull how Medicaid expansion might affect budgets

States consider how health legislation on Capitol Hill might affect their Medicaid programs and budgets.

18 Nov 2009

Tempest over new mammography guidelines affect health legislation, insurance guidelines

Newspapers across the country featured front-page follow-up stories on new mammogram recommendations today.

18 Nov 2009

Lee's Pharmaceutical granted exclusive license to Jennerex' lead product for HCC

Jennerex, Inc., a clinical-stage biotherapeutics company developing a proprietary breakthrough class of targeted oncolytic virus therapeutics, today announced in conjunction with Lee's Pharmaceutical Holdings, the execution of a collaboration and license agreement for Jennerex's lead product candidate, JX-594, in certain Asian territories.

18 Nov 2009

AT&T supports PADRES Contra El Cancer in campaign to raise awareness of childhood cancer

AT&T* today announced that it will launch the fourth annual campaign to raise awareness of childhood cancer and collect donations to support PADRES Contra El Cancer (PADRES), a nonprofit organization committed to improving the quality of life for Latino children who are battling the disease, beginning November 22. AT&T set a goal of raising $300,000 this year, which would mean a total donation of $1 million to PADRES since the campaign's inception in 2007.

18 Nov 2009

Roche Applied Science announces availability of new CIM-Plate 16 for their xCELLigence System

Roche Applied Science announces the availability of the new CIM-Plate 16 for their xCELLigence System for cell analysis, for use in cancer research. The 16-well culture plate features electronic sensors for the direct study of cell migration and invasion on the xCELLigence RTCA DP Instrument.

18 Nov 2009

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

CytRx Corporation, a biopharmaceutical company, today announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer.

18 Nov 2009

New data on Synta Pharmaceuticals' elesclomol presented at the AACR-NCI-EORTC Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today presented new data on the mechanism of action of elesclomol, a first-in-class oxidative stress inducer, at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics in Boston, Mass.

18 Nov 2009

Fiscal 2009 results announced by Opsens

Opsens Inc. today released its results for the year ended August, 31, 2009.

18 Nov 2009

Ionian Technologies receives supplemental funding from the Gates Foundation

Ionian Technologies, Inc., will continue its efforts to develop a rapid point-of-care diagnostics platform for use in the developing world with supplemental funding from the Bill & Melinda Gates Foundation. This grant from the Foundation will extend the total commitment to this program, which was initiated in November 2008, to $3 million over two years.

18 Nov 2009

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash.

18 Nov 2009

W. L. Gore to distribute QXMédical's Q50 Stent Graft Balloon Catheter

W. L. Gore & Associates today announced it has entered into a partnership with QXMédical, LLC, a medical device development and marketing company. As part of the agreement, Gore will distribute the Q50 Stent Graft Balloon Catheter which is designed for use with aortic stent grafts that treat abdominal aortic aneurysms (AAA) and thoracic aortic aneurysms (TAA).

18 Nov 2009

Unibased Systems Architecture and DST Technologies form a strategic relationship

Unibased Systems Architecture, Inc., a resource, scheduling, and OR management system provider, and DST Technologies, Inc., a process automation and work management solution provider, today announced they have formed a strategic relationship for the purpose of jointly marketing their solutions to better serve clients in the healthcare industry.

18 Nov 2009

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.

18 Nov 2009

House Medicare 'doc fix' vote likely Thursday amidst disputes about cost, role in health reform

"On Thursday, the House is expected to pass a $210 billion measure — known as the 'doc fix' — that will adjust Medicare payment rates to avoid a 21 percent cut in January and continuing cuts in the years ahead," The New York Times reports, adding: "The House originally included the provision in its big health care bill. But it was dropped because its steep cost would have meant the bill would add to future federal deficits, violating one of President Obama's central requirements for the health legislation."

18 Nov 2009

Medical News

CLASS Act, individual mandate draw new attention to health bills

A selection of today's opinions and editorials

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Seniors struggle with drug costs while Congress debates Medicare 'doughnut hole'

Green tea prevents the development of hepatic fibrosis in rat model of DMN-induced liver fibrosis

White House reports billions lost in improper payments for Medicare, other government programs

States mull how Medicaid expansion might affect budgets

Tempest over new mammography guidelines affect health legislation, insurance guidelines

Lee's Pharmaceutical granted exclusive license to Jennerex' lead product for HCC

AT&T supports PADRES Contra El Cancer in campaign to raise awareness of childhood cancer

Roche Applied Science announces availability of new CIM-Plate 16 for their xCELLigence System

CytRx plans Phase 2 clinical trial of its doxorubicin prodrug for advanced gastric cancer

New data on Synta Pharmaceuticals' elesclomol presented at the AACR-NCI-EORTC Conference

Fiscal 2009 results announced by Opsens

Ionian Technologies receives supplemental funding from the Gates Foundation

Epiphany Biosciences announces results from its valomaciclovir Phase 2b trial for shingles

W. L. Gore to distribute QXMédical's Q50 Stent Graft Balloon Catheter

Unibased Systems Architecture and DST Technologies form a strategic relationship

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

House Medicare 'doc fix' vote likely Thursday amidst disputes about cost, role in health reform

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News